Cynosure Management, LLC Repligen Corp Transaction History
Cynosure Management, LLC
- $615 Million
- Q2 2024
A detailed history of Cynosure Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cynosure Management, LLC holds 3,024 shares of RGEN stock, worth $435,093. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,024
Previous 1,652
83.05%
Holding current value
$435,093
Previous $303,000
25.74%
% of portfolio
0.06%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding RGEN
# of Institutions
497Shares Held
53.9MCall Options Held
423KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.09 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$729 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$663 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$250 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$205 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.98B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....